Journal
FEBS LETTERS
Volume 586, Issue 19, Pages 3000-3007Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.febslet.2012.07.048
Keywords
Omic; microRNA; Colon cancer; Personalized medicine
Funding
- Foundation Fournier-Majoie
- King Baudouin Foundation, Belgium
- William M. Keck Foundation grant
Ask authors/readers for more resources
Cancer omics data are exponentially created and associated with clinical variables, and important findings can be extracted based on bioinformatics approaches which can then be experimentally validated. Many of these findings are related to a specific class of non-coding RNA molecules called microRNAs (miRNAs) (post-transcriptional regulators of mRNA expression). The related research field is quite heterogeneous and bioinformaticians, clinicians, statisticians and biologists, as well as data miners and engineers collaborate to cure stored data and on new impulses coming from the output of the latest Next Generation Sequencing technologies. Here we review the main research findings on miRNA of the first 10 years in colon cancer research with an emphasis on possible uses in clinical practice. This review intends to provide a road map in the jungle of publications of miRNA in colorectal cancer, focusing on data availability and new ways to generate biologically relevant information out of these huge amounts of data. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available